Navigation Links
Kantar Health Uncovers Opportunities and Challenges for Biosimilars in Asia
Date:11/11/2013

New York, NY (PRWEB) November 12, 2013

Kantar Health, a leading global healthcare consulting firm, will release new details on biosimilar opportunities and challenges for pharmaceutical manufacturers in Asia at the EphMRA 2013 Asia Conference on November 14 in Singapore. Questa Lin, General Manager, Taiwan, and Simon Li, General Manager, China, will present.

In their presentation, “Uncover Biosimilars Opportunities and Challenges – Utilising Market Insights,” Ms. Lin and Mr. Li will provide a comprehensive understanding of the opportunities and barriers for developing biosimilars, how to apply market access strategies, and the research required to produce forecasting estimates.

In addition, Alice Lee, Regional Talent Director at Kantar Health, will participate in the panel discussion “Talent Management Issues” on November 13, which will focus on challenges in recruiting and retaining market researchers.

Kantar Health is a Silver Sponsor of the EphMRA 2013 Asia Conference. More information on this event can be found at http://www.ephmra.org/events/2013-asia-conference.aspx.

About Kantar Health
Kantar Health is a leading global healthcare consulting firm and trusted advisor to many pharmaceutical, biotech, and medical device and diagnostic companies worldwide. It combines evidence-based research capabilities with deep scientific, therapeutic and clinical knowledge, commercial development know-how, and brand and marketing expertise to help clients evaluate opportunities, launch products and maintain brand and market leadership.

Kantar Health deeply understands the influence of patients, payers and physicians, especially as they relate to the performance and payment of medicines and the delivery of healthcare services. Its 700+ healthcare industry specialists work across the product lifecycle, from preclinical development to launch, acting as catalysts to successful decision-making in life sciences and helping clients prioritize their product development and portfolio activities, differentiate their brands and drive product success post-launch. For more information, please visit http://www.kantarhealth.com.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11319731.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Patients Experience Impairments Just One Year After Knee Replacement Surgery, According to New Kantar Health Research
2. Kantar Health to Highlight Strategies for Accessing U.S. and EU Markets for Japan Pharma
3. Kantar Health to Highlight Role of Patient-Reported Outcomes in Russia
4. New Kantar Health Data Show Number of Newly Diagnosed Breast Cancer Patients in China Will Surpass U.S. by 2015
5. Biologic Treatment of Rheumatoid Arthritis Is Low in Brazil, According to Kantar Health Research
6. Treatment Rates of Prevalent Chronic Conditions Are Low in Brazil, According to Kantar Health Research
7. Kantar Health Americas CEO Mike Kelly Named to PharmaVOICE 100 for 2013
8. Kantar Health Launches CancerMPact Biomarker Analysis
9. Insulin Pump Therapy Provides Better Glycemic Control Among Type 1 Diabetics, According to Kantar Health Research
10. Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research
11. Kantar Health to Present at PBIRG Annual General Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
(Date:4/26/2017)... ... April 26, 2017 , ... Want to ... website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced plant breeding technology is ... better food, with fewer resources. It highlights the business’ principles, research and collaboration ...
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... human performance, is proud to announce that it has received 510(k) clearance from ... the MyoCycle Home and the MyoCycle Pro. , Both devices are stationary cycling ...
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017 Research and Markets has ... Manufacturing Services Market Analysis By Service (Manufacturing, Research), By Country, ... - 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing ... 2025 Low drug registration cost in Latin American ...
(Date:4/19/2017)... 2017 Global Surgical Drainage Device Market: Overview ... to remove excess liquid and air. The fluid to ... or lymph. Surgical drains are used in a wide ... surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. Common use ... accumulation of fluid e.g. blood or pus. Surgical drains ...
(Date:4/19/2017)... , April 19, 2017 ... an immune response in pets such as canine, ... are of various types such as Attenuated Live ... Vaccines, DNA Vaccines and Recombinant Vaccines. Attenuated live ... virus or bacteria, which have been weakend under ...
Breaking Medicine Technology: